Sign in

You're signed outSign in or to get full access.

Bethany A. Uhlein

Vice President and Ombudsman at Gabelli Healthcare & WellnessRx Trust
Executive

About Bethany A. Uhlein

Bethany A. Uhlein serves as Vice President and Ombudsman of Gabelli Healthcare & WellnessRx Trust (GRX) and has held the role since May 2017; her year of birth is 1990, and her business address is One Corporate Center, Rye, NY 10580-1422 . She is also Senior Vice President of GAMCO Investors, Inc. since 2021, reflecting broader responsibilities across the Gabelli Fund Complex . GRX’s proxy disclosures present only aggregate cash compensation for officers and do not link her pay to fund performance metrics such as TSR, revenue or EBITDA; no stock or option awards are reported for officers, indicating the absence of equity-based performance incentives in her disclosed compensation .

Past Roles

OrganizationRoleYearsStrategic Impact
GAMCO Asset Management Inc.Associate2013–2015Early career investment/operations experience within Gabelli ecosystem
GAMCO Asset Management Inc.Assistant Vice President2015–2017Expanded responsibilities prior to GRX officer appointment
Gabelli Fund Complex (closed-end funds)Vice President and OmbudsmanSince May 2017Officer/ombudsman for closed-end funds in the complex, supporting fund governance and investor-facing functions

External Roles

OrganizationRoleYearsNotes
GAMCO Investors, Inc.Senior Vice PresidentSince 2021Senior role at adviser-level company aligned with Gabelli Fund Complex

Fixed Compensation

MetricFY 2019FY 2020FY 2023FY 2024
Aggregate Compensation from the Fund (USD)$75,000 $75,000 $74,942 $75,622

Notes: GRX proxies disclose only “Aggregate Compensation from the Fund” for officers who are compensated by the Fund rather than the Adviser; no breakdown into base salary vs. bonus or other components is provided .

Performance Compensation

  • No annual bonus targets, actual bonus payouts, stock awards (RSUs/PSUs), option grants, vesting schedules, or performance metrics tied to officer compensation are disclosed for GRX officers (including Ms. Uhlein) in the proxy statements reviewed .

Equity Ownership & Alignment

  • Beneficial ownership: The GRX proxies present officer/trustee ownership tables; Ms. Uhlein is not listed among the “Executive Officers” shown in the beneficial ownership tables for 2023 and 2024 (names listed are John C. Ball, Peter Goldstein, and Richard J. Walz), and no specific share ownership is disclosed for her .
  • Pledging/hedging: No disclosures regarding pledging or hedging of stock for Ms. Uhlein were found in GRX proxies .
  • Stock ownership guidelines: GRX proxies discuss trustee dollar ranges and fund complex holdings, but do not disclose officer stock ownership guidelines applicable to Ms. Uhlein .

Employment Terms

ItemDisclosure
PositionVice President and Ombudsman
Year of Birth1990
Start Date in Current RoleSince May 2017
Term of OfficeOfficers hold office for an indefinite term until resignation/retirement or successor election/qualification
AddressOne Corporate Center, Rye, NY 10580-1422
Severance / Change-of-ControlNot disclosed in GRX proxies reviewed
Non-Compete / Non-Solicit / Garden LeaveNot disclosed in GRX proxies reviewed
Clawback / Tax Gross-ups / PerquisitesNot disclosed in GRX proxies reviewed

Additional Context from GRX Proxy Materials

  • GRX’s officer roster includes Ms. Uhlein alongside other fund officers; the proxies emphasize fund governance structures and do not tie officer pay to explicit operating or performance metrics .
  • The compensation tables are scoped to fund-level payments to trustees and, when applicable, officers paid by the Fund rather than the Adviser; the presentations for 2019, 2020, 2023, and 2024 show only aggregate figures for Ms. Uhlein, without equity compensation .
  • No Form 8-K Item 5.02 appointment/resignation or employment agreements for Ms. Uhlein were found for GRX in the period searched [Search: 8-K/8-K 5.02 for GRX; no matches].

Investment Implications

  • Compensation alignment: Disclosures indicate a cash-based, modest aggregate compensation paid by the Fund to Ms. Uhlein, with no reported equity awards, options, or performance-linked metrics—limiting direct pay-for-performance alignment at the officer level .
  • Insider selling pressure: Absence of disclosed equity awards and vesting schedules reduces typical insider selling triggers tied to vesting or option exercises; beneficial ownership details for Ms. Uhlein are not disclosed, limiting visibility into potential trading signals .
  • Retention risk: The indefinite term of office and long tenure since 2017 suggest stability; however, lack of disclosed severance/change-of-control protections leaves limited insight into contractual retention levers .
  • Governance/role scope: Her parallel role as Senior VP at GAMCO Investors, Inc. indicates strong integration with the adviser organization and the closed-end fund complex, supporting continuity in fund operations and investor relations/ombudsman functions .

Methodology note: We searched GRX DEF 14A proxies (2020–2025) and 8-Ks for officer-specific compensation structures, ownership, contracts, and governance; relevant disclosures were limited to officer identity, tenure, and aggregate cash compensation. Attempts to fetch Form 4 insider trades via the insider-trades skill were unsuccessful due to an authorization error; therefore, no additional trading/ownership detail beyond proxy tables could be incorporated at this time.